• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类抑制信号调节蛋白α的多态性不影响其与配体 CD47 的结合。

Polymorphisms in the human inhibitory signal-regulatory protein α do not affect binding to its ligand CD47.

机构信息

From the Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.

出版信息

J Biol Chem. 2014 Apr 4;289(14):10024-8. doi: 10.1074/jbc.M114.550558. Epub 2014 Feb 18.

DOI:10.1074/jbc.M114.550558
PMID:24550402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3974974/
Abstract

CD47 is a widely distributed membrane protein that interacts with signal-regulatory protein α (SIRPα), an inhibitory receptor on myeloid cells that gives a "don't-eat-me" signal. Manipulation of the interaction is of considerable interest in the immunotherapy of cancer and in xenotransplantation. The amino-terminal ligand binding domain of SIRPα is highly polymorphic in contrast to the single Ig-like domain of CD47. There is confusion as to whether the polymorphisms will affect ligand binding, but this is an important point for this interaction and other paired receptors being considered as targets for therapy. We show by x-ray crystallography that one human SIRPα allele differing in 13 amino acid residues has a very similar binding site and that several different alleles all bind CD47 with similar affinity as expected because the residues are mostly surface-exposed and distant from the binding site. A peptide from the binding site of CD47 has been reported to mimic the CD47 interaction with SIRPα, but we could find no binding. We discuss the possible pitfalls in determining the affinity of weak interactions and also speculate on how SIRPα polymorphisms may have been selected by pathogens and how this may also be true in other paired receptors such as the KIRs.

摘要

CD47 是一种广泛分布的膜蛋白,与信号调节蛋白 α(SIRPα)相互作用,SIRPα 是髓系细胞上的一种抑制性受体,能发出“不要吃我”的信号。该相互作用的人为操控在癌症的免疫疗法和异种移植中具有重要意义。与 CD47 的单一免疫球蛋白样结构域相反,SIRPα 的氨基末端配体结合域高度多态性。人们对于这些多态性是否会影响配体结合存在争议,但这是该相互作用以及其他配对受体被视为治疗靶点的一个重要问题。我们通过 X 射线晶体学表明,一个人类 SIRPα 等位基因有 13 个氨基酸残基的差异,其具有非常相似的结合位点,并且几种不同的等位基因都以预期的相似亲和力结合 CD47,因为这些残基主要位于表面且远离结合位点。据报道,来自 CD47 结合位点的肽可以模拟 CD47 与 SIRPα 的相互作用,但我们没有发现任何结合。我们讨论了确定弱相互作用亲和力的可能陷阱,并推测 SIRPα 多态性如何被病原体选择,以及这在其他配对受体(如 KIR)中是否也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178f/3974974/6fb07a67f3b0/zbc0181480770004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178f/3974974/9589224fca80/zbc0181480770001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178f/3974974/3cea44bf6b1b/zbc0181480770002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178f/3974974/2f055128fe73/zbc0181480770003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178f/3974974/6fb07a67f3b0/zbc0181480770004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178f/3974974/9589224fca80/zbc0181480770001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178f/3974974/3cea44bf6b1b/zbc0181480770002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178f/3974974/2f055128fe73/zbc0181480770003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/178f/3974974/6fb07a67f3b0/zbc0181480770004.jpg

相似文献

1
Polymorphisms in the human inhibitory signal-regulatory protein α do not affect binding to its ligand CD47.人类抑制信号调节蛋白α的多态性不影响其与配体 CD47 的结合。
J Biol Chem. 2014 Apr 4;289(14):10024-8. doi: 10.1074/jbc.M114.550558. Epub 2014 Feb 18.
2
Surfactant protein D (Sp-D) binds to membrane-proximal domain (D3) of signal regulatory protein α (SIRPα), a site distant from binding domain of CD47, while also binding to analogous region on signal regulatory protein β (SIRPβ).表面活性蛋白 D(Sp-D)与信号调节蛋白 α(SIRPα)的膜近端结构域(D3)结合,该位点与 CD47 的结合域相距较远,同时也与信号调节蛋白 β(SIRPβ)的类似区域结合。
J Biol Chem. 2012 Jun 1;287(23):19386-98. doi: 10.1074/jbc.M111.324533. Epub 2012 Apr 16.
3
Structure of signal-regulatory protein alpha: a link to antigen receptor evolution.信号调节蛋白α的结构:与抗原受体进化的联系
J Biol Chem. 2009 Sep 25;284(39):26613-9. doi: 10.1074/jbc.M109.017566. Epub 2009 Jul 23.
4
"Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.作为信号调节蛋白α(SIRPα)拮抗剂的高亲和力CD47胞外域的“维可牢”工程,可增强抗体依赖性细胞吞噬作用。
J Biol Chem. 2015 May 15;290(20):12650-63. doi: 10.1074/jbc.M115.648220. Epub 2015 Apr 2.
5
Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.通过单独的信号调节蛋白结构以及与CD47复合的结构所解释的配对受体特异性。
Mol Cell. 2008 Jul 25;31(2):266-77. doi: 10.1016/j.molcel.2008.05.026.
6
The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.信号调节蛋白 α(SIRPα)与 CD47 的相互作用:结构、功能与治疗靶点。
Annu Rev Immunol. 2014;32:25-50. doi: 10.1146/annurev-immunol-032713-120142. Epub 2013 Nov 6.
7
The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors.巨噬细胞信号调节蛋白α(SIRPα)抑制性受体的结构揭示了一个类似于T细胞受体所使用的结合面。
J Biol Chem. 2007 May 11;282(19):14567-75. doi: 10.1074/jbc.M611511200. Epub 2007 Mar 16.
8
Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site.CD47与人类信号调节蛋白α相互作用的系统发育差异揭示了物种特异性位点。对结合位点的影响。
J Biol Chem. 2007 Jan 19;282(3):1805-18. doi: 10.1074/jbc.M603923200. Epub 2006 Nov 10.
9
The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47.信号调节蛋白α(SIRPα)顺式二聚化在与 CD47 结合中的作用。
J Biol Chem. 2010 Dec 3;285(49):37953-63. doi: 10.1074/jbc.M110.180018. Epub 2010 Sep 7.
10
A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology.一种同质的 SIRPα-CD47 细胞结合配体检测法:在免疫肿瘤学中小分子药物开发的应用。
PLoS One. 2020 Apr 2;15(4):e0226661. doi: 10.1371/journal.pone.0226661. eCollection 2020.

引用本文的文献

1
Donor-recipient mismatch at the locus adversely affects kidney allograft outcomes.该位点供体 - 受体不匹配会对肾移植同种异体移植物的预后产生不利影响。
Sci Transl Med. 2025 Jul 16;17(807):eady1135. doi: 10.1126/scitranslmed.ady1135.
2
Development of small molecule drugs targeting immune checkpoints.针对免疫检查点的小分子药物的研发。
Cancer Biol Med. 2024 May 9;21(5):382-99. doi: 10.20892/j.issn.2095-3941.2024.0034.
3
Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies.

本文引用的文献

1
The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.信号调节蛋白 α(SIRPα)与 CD47 的相互作用:结构、功能与治疗靶点。
Annu Rev Immunol. 2014;32:25-50. doi: 10.1146/annurev-immunol-032713-120142. Epub 2013 Nov 6.
2
Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution.CD200/CD200 受体家族的结构及其对拓扑结构、调控和进化的影响。
Structure. 2013 May 7;21(5):820-32. doi: 10.1016/j.str.2013.03.008. Epub 2013 Apr 18.
3
'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach.
BMS-986351 是一种针对 SIRPα 的抗体,与调理抗体联合使用时可增强巨噬细胞介导的肿瘤吞噬作用。该抗体的发现和临床前活性研究。
Cancer Res Commun. 2024 Feb 22;4(2):505-515. doi: 10.1158/2767-9764.CRC-23-0634.
4
The Impact of Patterns in Linkage Disequilibrium and Sequencing Quality on the Imprint of Balancing Selection.连锁不平衡和测序质量模式对平衡选择印迹的影响。
Genome Biol Evol. 2024 Feb 1;16(2). doi: 10.1093/gbe/evae009.
5
Binding Mechanism of CD47 with SIRPα Variants and Its Antibody: Elucidated by Molecular Dynamics Simulations.CD47 与 SIRPα 变体及其抗体的结合机制:分子动力学模拟阐明。
Molecules. 2023 Jun 7;28(12):4610. doi: 10.3390/molecules28124610.
6
BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells.BYON4228 是一种全等位基因拮抗型 SIRPα 抗体,可增强抗体包被的肿瘤细胞的破坏作用,且不与 T 细胞上的 SIRPγ 结合。
J Immunother Cancer. 2023 Apr;11(4). doi: 10.1136/jitc-2022-006567.
7
Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A).人 CD47 与工程化 SIRPα.D1(N80A)复合物的晶体结构。
Molecules. 2022 Aug 30;27(17):5574. doi: 10.3390/molecules27175574.
8
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils.靶向CD47-SIRPα天然免疫检查点以增强中性粒细胞在癌症中的抗体治疗作用。
Cancers (Basel). 2022 Jul 11;14(14):3366. doi: 10.3390/cancers14143366.
9
SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies.SIRPα 错配与淋巴恶性肿瘤相关造血干细胞移植后复发保护和慢性移植物抗宿主病相关。
Front Immunol. 2022 Jul 7;13:904718. doi: 10.3389/fimmu.2022.904718. eCollection 2022.
10
Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis.阻断 CD47 可通过 trogocytosis 增强巨噬细胞在肾细胞癌中的抗肿瘤作用。
Sci Rep. 2022 Jul 22;12(1):12546. doi: 10.1038/s41598-022-16766-3.
通过自上而下的细胞膜涂层方法对纳米颗粒进行“自我标记”功能化。
Nanoscale. 2013 Apr 7;5(7):2664-8. doi: 10.1039/c3nr00015j.
4
Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles.最小“自我”肽可抑制吞噬清除作用并增强纳米颗粒的递呈。
Science. 2013 Feb 22;339(6122):971-5. doi: 10.1126/science.1229568.
5
CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease.CD47:一种细胞表面糖蛋白,在健康和疾病状态下调节造血细胞的多种功能。
ISRN Hematol. 2013;2013:614619. doi: 10.1155/2013/614619. Epub 2013 Jan 21.
6
Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution.可变 NK 细胞受体及其 MHC Ⅰ类配体在免疫、生殖和人类进化中的作用。
Nat Rev Immunol. 2013 Feb;13(2):133-44. doi: 10.1038/nri3370. Epub 2013 Jan 21.
7
Molecular recognition of paired receptors in the immune system.免疫系统中配对受体的分子识别。
Front Microbiol. 2012 Dec 31;3:429. doi: 10.3389/fmicb.2012.00429. eCollection 2012.
8
How do pathogens drive the evolution of paired receptors?病原体如何驱动配对受体的进化?
Eur J Immunol. 2013 Feb;43(2):303-13. doi: 10.1002/eji.201242896.
9
Association study identifying polymorphisms in CD47 and other extracellular matrix pathway genes as putative prognostic markers for colorectal cancer.CD47 及其他细胞外基质通路基因多态性与结直肠癌预后相关性的关联研究:候选预后标志物。
Int J Colorectal Dis. 2013 Feb;28(2):173-81. doi: 10.1007/s00384-012-1541-4. Epub 2012 Jul 28.
10
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications.CD47-SIRPα 通路在癌症免疫逃逸中的作用及其潜在的治疗意义。
Curr Opin Immunol. 2012 Apr;24(2):225-32. doi: 10.1016/j.coi.2012.01.010. Epub 2012 Feb 4.